By Steve Moore | Monday 22 May 2023
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Last week I wrote on pharmaceutical development company Nuformix (NFX) “absolutely delighted with the data we've generated”. Er, how’s the balance sheet now?”, concluding still a financial red flags fluttering Sell. What about now following “unaudited results for the twelve months ended 31 March 2023 following the change in the company's accounting reference date from 31 March to 30 September”?
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.
Filed under:
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Time left: 13:35:35